DAFTAR PUSTAKA

1. Wang Y, Alexander JS. Placental Pathophysiology in Preclampsia. Pathophysiology

2000; 6: 261-270.
2. Cunningham FG, Mac Donald PC, Gant NF, Leveno KJ, Gilstrap LC, Hankins GD et
al. 2001, Hypertension Disorders in Pregnancy. Williams Obstetrics. 21th ed.
London: Prentice-Hall International, 2001: 567-618.
3. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN. Maternal
Mortality with HELPP (Hemolysis, Elevated Liver Enzymes, And Low Platelets)
Syndrome. Am J Obstet Gynecol 1999; 181: 924-928.
4. Prasetyorini, N, 2009. Penanganan Preeklampsia dan Eklampsia. Seminar POGI
Cabang Malang. Divisi Kedokteran Feto Maternal - FKUB/RSSA Malang.
5. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. Jul
30 1998;339(5):313-20.
6. Koonin LM, MacKay AP, Berg CJ, et al. Pregnancy-related mortality surveillance-United States, 1987-1990. MMWR CDC SurveillSumm. Aug 8 1997;46(4):17-36.
7. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management
of preeclampsia. JAMA. Jun 26 2002;287(24):3183-6.
8. Taylor RN, de Groot CJ, Cho YK, et al. Circulating factors as markers and mediators
of
endothelial
cell
dysfunction
in
preeclampsia. SeminReprodEndocrinol. 1998;16(1):17-31.
9. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. Jun
10 2005;308(5728):1592-4.
10. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human
cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective
endovascular invasion in this syndrome?. J Clin Invest. May 1 1997;99(9):2152-64.
11. Friedman SA, Schiff E, Emeis JJ, et al. Biochemical corroboration of endothelial
involvement in severe preeclampsia. Am J Obstet Gynecol. Jan 1995;172(1 Pt 1):2023.
12. American College of Obstetricians and Gynecologists. Hypertension in pregnancy.
ACOG Technical Bulletin No. 219. Washington DC: 1996.
13. ACOG. Committee on Practice Bulletins-Obstetrics. Diagnosis and management of
preeclampsia and eclampsia. Obstet Gynecol. 2001;98:159-67.
14. Report of the National High Blood Pressure Education Program Working Group on
High Blood Pressure in Pregnancy. Am J Obstet Gynecol. Jul 2000;183(1):S1-S22.
15. Waugh JJ, Clark TJ, Divakaran TG, et al. Accuracy of urinalysis dipstick techniques
in
predicting
significant
proteinuria
in
pregnancy. Obstet
Gynecol. Apr 2004;103(4):769-77.

38

16. Durnwald C, Mercer B. A prospective comparison of total protein/creatinine ratio

versus 24-hour urine protein in women with suspected preeclampsia. Am J Obstet
Gynecol. Sep 2003;189(3):848-52.
17. Chesley LC. Hypertensive Disorders in Pregnancy, AppletonCenturyCrofts. New
York: 1978.
18. Fisher KA, Luger A, Spargo BH, et al. Hypertension in pregnancy: clinicalpathological
correlations
and
remote
prognosis. Medicine
(Baltimore). Jul 1981;60(4):267-76.
19. Barron WM, Heckerling P, Hibbard JU, et al. Reducing unnecessary coagulation
testing in hypertensive disorders of pregnancy. Obstet Gynecol. Sep 1999;94(3):36470.
20. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis,
elevated liver enzymes, and low platelet count. Obstet Gynecol. May 2004;103(5 Pt
1):981-91.
21. Diamond JA, PhillipsRA. Hypertensive Heart Disease. Hypertens Res Vol. 28, No. 3
(2005). On International journal of obesity.
22. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet
Gynecol. Feb 2005;105(2):402-10.
23. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who
developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet
Gynecol. Jan 2000;95(1):24-8.
24. Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly
higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet
Gynecol. Jan 2002;186(1):66-71.
25. Barton JR, Witlin AG, Sibai BM. Management of mild preeclampsia. ClinObstet
Gynecol. Sep 1999;42(3):455-69.
26. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative
Eclampsia Trial. Lancet. Jun 10 1995;345(8963):1455-63.
27. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from
recent trials. Am J Obstet Gynecol. Jun 2004;190(6):1520-6.
28. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and
eclampsia. Obstet Gynecol. Nov 1998;92(5):883-9.
29. Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe
hypertension in pregnancy: meta-analysis. BMJ. Oct 25 2003;327(7421):955-60.
30. Creasy RK, Resnik R, Iams JD. Maternal-Fetal Medicine: Principles and Practice. 5th
ed. 2004:859-899.
31. Martin JN Jr, Perry KG Jr, Blake PG, et al. Better maternal outcomes are achieved
with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver
enzymes,
and
thrombocytopenia)
syndrome. Am
J
Obstet
Gynecol. Nov 1997;177(5):1011-7.
32. Martin JN Jr, Thigpen BD, Rose CH, et al. Maternal benefit of high-dose intravenous
corticosteroid
therapy
for
HELLP
syndrome. Am
J
Obstet
Gynecol. Sep 2003;189(3):830-4.
33. Broek van den NR, Letsky EA. Etiology of anemia in pregnancy in south Malawi.
Am. J. Clin. Nutr. 2000; 72(1):247S-256S.
39

34. Lang, RM. Pharmacologic Management of Heart Failure in Pregnancy. [online].[cited

2016 December 10];

39